Glycation cross-link breakers to increase resistance to enzymatic degradation

Patent metadata

Field	Value
Publication number	US-9309304-B2
Application number	US-201313895527-A
Country	US
Kind code	B2
Filing date	May 16, 2013
Priority date	May 16, 2012
Publication date	Apr 12, 2016
Grant date	Apr 12, 2016

Abstract

The present invention relates to a method to treat a grafts, implant, scaffold, and constructs, including allografts, xenografts, autografts, and prosthetics comprising collagen, with an inhibitor of collagen cross-links and/or advanced glycation endproducts (AGE), in order to alleviate the mechanical weakness induced by the cross-links. The invention also provides for kits for use in the operating theater during autograft, allograft or xenograft procedures, or for preparing allograft, xenografts or prosthetics that have not been already treated prior to packaging. The kit comprises a first agent or agents that inhibit collagen cross-links and/or advanced glycation endproducts, instructions for use, optionally a wash or rinse agent, and a device for containing the graft and first agent.

First claim

The invention claimed is:

1. A method of breaking, removing and/or eliminating advanced glycation end-product cross-links in collagen in a graft, implant, scaffold, or construct consisting of tissue isolated from a mammal and suitable for implantation into a subject for the treatment, repair or replacement of defects or injury in a biological tissue or organ, comprising incubating, prior to implantation into the subject, said graft, implant, scaffold or construct with an agent that breaks, removes, and/or eliminates advanced glycation end-product cross-links in said collagen for a time and at a temperature during which the advanced glycation end-product cross-links in said collagen in said graft, implant, scaffold, or construct are broken, removed, and/or eliminated, followed by rinsing or washing the agent from said graft, implant, scaffold or construct, wherein said agent is no longer present in the graft, implant, scaffold or construct prior to implantation of said graft, implant, scaffold or construct into the subject, and wherein said agent is selected from the group consisting of ALT-462, ALT-486, ALT-946, N-phenacylthiazolium bromide (PTB), TRC4186, TRC4149, C36 and C16.

2. The method of claim 1 , wherein the graft, implant, scaffold, or construct is an autograft, an isograft, an allograft, or a xenograft.

3. The method of claim 1 , wherein the biological tissue is musculoskeletal, vascular, epidermal, dermal, connective, neurological, or dental.

4. The method of claim 1 , wherein the organ is skin, heart, lung esophagus, kidney, liver, or lymph glands.

5. The method of claim 1 , wherein the subject is a mammal.

6. The method of claim 5 , wherein the mammal is a human, a non-human primate, an ovine, a porcine, an equine, a canine, a feline, or a bovine.

7. The method of claim 1 , wherein graft, implant, scaffold, or construct is incubated, prior to implantation into the subject with the agent that breaks, removes, and/or eliminates cross-links in collagen for a time of about one (1) minute to about seventy-two (72) hours.

8. The method of claim 1 , wherein graft, implant, scaffold, or construct is incubated, prior to implantation into the subject with the agent that, breaks, removes, and/or eliminates cross-links in collagen for a time of about one (1) minute to about one hundred and twenty (120) minutes.

9. The method of claim 1 , wherein graft, implant, scaffold, or construct is incubated, prior to implantation into the subject with the agent that, breaks, removes, and/or eliminates cross-links in collagen for a time of about four (4) to about sixteen (16) hours.

10. The method of claim 1 , wherein graft, implant, scaffold, or construct is incubated, prior to implantation into the subject with the agent that, breaks, removes, inhibits and/or eliminates cross-links in collagen at a temperature of between about 4° C. and about 37° C.

Assignees

• New York Soc Ruptured & Crippled Maintaining Hospital For Special Surgery
• Univ Cornell

Inventors

• Bourne Jonathan W
• Torzilli Peter A

Classifications

• C07K14/78 Primary

  Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG] · CPC title